Vimarsana
Biggest News Aggregation in the World

Page 7 - Risk Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Information Today - Breaking & Trending Today

Interview: „TikTok's power to say no is shrinking by the day" – netzpolitik.org - Vimarsana News

Interview: „TikTok's power to say no is shrinking by the day" – netzpolitik.org

TikTok is struggling to convince Western politicians it is not a security threat. But governments are right to ban the app from official devices, says China expert Rebecca Arcesati. Still she warns the biggest threat is Europe and the US giving up on their democratic values in dealing with TikTok.

AGG Food & Drug Newsletter - August 2023 | Arnall Golden Gregory LLP - Vimarsana News

AGG Food & Drug Newsletter - August 2023 | Arnall Golden Gregory LLP

Arnall Golden Gregory LLP's Food & Drug Newsletter is a roundup of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food &...

ByteDance spends millions lobbying, outpacing prior years amid crackdown on TikTok's China ties • OpenSecrets - Vimarsana News

ByteDance spends millions lobbying, outpacing prior years amid crackdown on TikTok's China ties • OpenSecrets

ByteDance spent $4.28 million on federal lobbying during the first half of this year as lawmakers cracked down on TikTok's ties to China.

FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Sheppard Mullin Richter & Hampton LLP

On June 27, 2023, the Food and Drug Administration (FDA) issued its final guidance for the presentation of “Quantitative Efficacy and Risk Information” in direct-to-consumer (DTC)...

OPDP Issues Final Guidance on Best Practices for Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Foley Hoag LLP - Vimarsana News

OPDP Issues Final Guidance on Best Practices for Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Foley Hoag LLP

On June 27, 2023, the Food and Drug Administration’s ("FDA") Office of Prescription Drug Promotion ("OPDP") published a final guidance (the "Final Guidance") on Presenting Quantitative...